Could it be time to consider buying CSL shares?
A number of Australia’s leading brokers have given their verdict on the CSL share price in recent months. And as you might expect due to COVID-19 uncertainties, opinion is largely divided on whether now is a good time to consider buying CSL shares.
Below is a summary of what brokers are saying about CSL shares in July 2021.
Citi
Citi currently has a neutral rating and $310.00 CSL share price target. This implies potential upside of 11% over the next 12 months. Citi is also forecasting a CSL dividend of $3.14 per share in FY 2021.
Goldman Sachs
Goldman Sachs has a neutral rating and CSL share price target of $305.00. If CSL shares hit this level, it will mean a gain of 9.2%. In addition, Goldman has pencilled in a CSL dividend of $2.81 this year.
Morgans
Morgans currently has an add rating and CSL share price target of $301.10. This represents a potential return of 7.9%. The broker is also forecasting a CSL dividend of $2.86 per share in FY 2021.
UBS
UBS is the most bullish broker with a buy rating and CSL share price target of $330.00. This implies potential upside of 18.2% over the next 12 months. UBS’ analysts are forecasting a CSL dividend of ~$2.33 per share in 2021.
Broker comments
The team at Goldman Sachs explained why they are neutral on the CSL share price.
Goldman said: “We are Neutral rated on CSL. Our 12-month TP of A$305 is based on our target NTM EV/EBITDA multiple of 28.9x. Key upside risks include: (1) Faster-than-expected recovery in plasma collections; (2) More supportive pricing dynamic than we already expect; (3) Positive results from the pipeline. Key downside risks include: (1) Extent of disruption to plasma collections; (2) Threat of mRNA/competitive approaches to Seqirus vaccine business; (3) Competitive product launches; (4) Plasma donor fee inflation.”
- Forums
- ASX - By Stock
- CSL
- Could it be time to consider buying CSL shares ?
Could it be time to consider buying CSL shares ?
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CSL (ASX) to my watchlist
(20min delay)
|
|||||
Last
$283.05 |
Change
3.470(1.24%) |
Mkt cap ! $136.7B |
Open | High | Low | Value | Volume |
$281.90 | $284.50 | $281.02 | $168.3M | 594.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 1012 | $283.05 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$283.47 | 3676 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 35 | 283.000 |
1 | 2457 | 282.930 |
1 | 990 | 282.880 |
1 | 100 | 282.820 |
1 | 580 | 282.800 |
Price($) | Vol. | No. |
---|---|---|
283.470 | 3676 | 1 |
283.500 | 500 | 1 |
283.890 | 194 | 1 |
284.000 | 250 | 1 |
284.200 | 20 | 1 |
Last trade - 16.10pm 15/05/2024 (20 minute delay) ? |
|
|||||
Last
$283.87 |
  |
Change
3.470 ( 1.68 %) |
|||
Open | High | Low | Volume | ||
$282.06 | $284.50 | $281.58 | 26577 | ||
Last updated 15.59pm 15/05/2024 ? |
Featured News
CSL (ASX) Chart |
The Watchlist
SS1
SUN SILVER LIMITED
Gerard O’Donovan, Executive Director
Gerard O’Donovan
Executive Director
SPONSORED BY The Market Online